rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
CADILA HEALTHCARE LTD. - Zydus receives approval from USFDA to initiate Phase 2 clinical trials of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in USA
Download announcement < Back
04 Jun 2016
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated June 04, 2016 titled &quot;Zydus receives approval from USFDA to initiate Phase 2 clinical trials of Saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in USA&quot;
View all announcements for CADILA HEALTHCARE LTD. Source: BSE India